Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-10-26

Clinical Trial Update: CHLOROQUINE FOR MAINTENANCE REMISSION OF AUTOIMMUNE HEPATITIS [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating chloroquine for maintaining remission in autoimmune hepatitis has been completed. The study was sponsored by the University of…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chloroquine (chloroquine)

Snippet

Sponsor: University of Sao Paulo General Hospital | Conditions: Hepatitis, Autoimmune | Phase 4 | Status: COMPLETED